Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: Relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?

Abstract

Tamoxifen, 4-hydroxytamoxifen, nafoxidine, 17 β-oestradiol and ICI 164,384 were all found to protect rat liver nuclei against Fe(III)-ascorbate dependent lipid peroxidation. The order of effectiveness of these compounds was 4-hydroxytamoxifen > 17 β-oestradiol > nafoxidine > tamoxifen > ICI 164,384. This protection by tamoxifen against the formation of the genotoxicreactive-intermediates and products of lipid peroxidation in the nuclear membrane could be important in the prevention of nuclear DNA damage and thus carcinogenesis. This possible anticarcinogenic benefit of tamoxifen treatment could be important in long-term therapy with tamoxifen (and future derivatives) and in its proposed use in the prevention of breast cancer.